Investor Zone

Welcome to the Investor Zone.

Here we will share our annual reports and regulatory filings. Synthimed is dedicated to driving sustainable growth and delivering long-term value through targeted pharmaceutical innovation. 

Sr. No
File
Action
1.
Annual Return 2024
2.
Annual Return 2025